<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DADB-v1.0: A Therapeutic Decathlon for De Novo Antibody Design</title>
    <meta name="description" content="DADB-v1.0: The first comprehensive benchmark for therapeutic antibody design. Join us in building the gold standard for evaluating AI-driven antibody discovery platforms.">
    <style>
        :root {
            --primary: #1a5276;
            --secondary: #2874a6;
            --accent: #e74c3c;
            --success: #27ae60;
            --warning: #f39c12;
            --purple: #8e44ad;
            --dark: #2c3e50;
            --light: #ecf0f1;
            --gray: #95a5a6;
            --text: #2c3e50;
            --bg: #ffffff;
            --bg-alt: #f8f9fa;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            line-height: 1.7;
            color: var(--text);
            background: var(--bg);
        }
        
        /* Hero Section */
        .hero {
            background: linear-gradient(135deg, var(--primary) 0%, var(--secondary) 100%);
            color: white;
            padding: 4rem 2rem 6rem;
            text-align: center;
            position: relative;
            overflow: hidden;
        }
        
        .hero::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url("data:image/svg+xml,%3Csvg width='60' height='60' viewBox='0 0 60 60' xmlns='http://www.w3.org/2000/svg'%3E%3Cg fill='none' fill-rule='evenodd'%3E%3Cg fill='%23ffffff' fill-opacity='0.05'%3E%3Cpath d='M36 34v-4h-2v4h-4v2h4v4h2v-4h4v-2h-4zm0-30V0h-2v4h-4v2h4v4h2V6h4V4h-4zM6 34v-4H4v4H0v2h4v4h2v-4h4v-2H6zM6 4V0H4v4H0v2h4v4h2V6h4V4H6z'/%3E%3C/g%3E%3C/g%3E%3C/svg%3E");
            opacity: 0.3;
        }
        
        .hero-content {
            position: relative;
            max-width: 900px;
            margin: 0 auto;
        }
        
        .hero h1 {
            font-size: 2.8rem;
            font-weight: 800;
            margin-bottom: 1rem;
            line-height: 1.2;
        }
        
        .hero .subtitle {
            font-size: 1.4rem;
            opacity: 0.95;
            margin-bottom: 2rem;
            font-weight: 300;
        }
        
        .hero .version {
            display: inline-block;
            background: rgba(255,255,255,0.2);
            padding: 0.4rem 1rem;
            border-radius: 20px;
            font-size: 0.9rem;
            margin-bottom: 2rem;
        }
        
        .cta-buttons {
            display: flex;
            gap: 1rem;
            justify-content: center;
            flex-wrap: wrap;
            margin-top: 2rem;
        }
        
        .btn {
            display: inline-flex;
            align-items: center;
            gap: 0.5rem;
            padding: 1rem 2rem;
            border-radius: 8px;
            font-weight: 600;
            text-decoration: none;
            transition: all 0.3s ease;
            border: none;
            cursor: pointer;
            font-size: 1rem;
        }
        
        .btn-primary {
            background: white;
            color: var(--primary);
        }
        
        .btn-primary:hover {
            transform: translateY(-2px);
            box-shadow: 0 10px 30px rgba(0,0,0,0.2);
        }
        
        .btn-secondary {
            background: transparent;
            color: white;
            border: 2px solid rgba(255,255,255,0.5);
        }
        
        .btn-secondary:hover {
            background: rgba(255,255,255,0.1);
            border-color: white;
        }
        
        /* Container */
        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 0 2rem;
        }
        
        /* Section Styles */
        section {
            padding: 4rem 0;
        }
        
        .section-header {
            text-align: center;
            margin-bottom: 3rem;
        }
        
        .section-header h2 {
            font-size: 2.2rem;
            color: var(--dark);
            margin-bottom: 1rem;
        }
        
        .section-header p {
            font-size: 1.2rem;
            color: var(--gray);
            max-width: 700px;
            margin: 0 auto;
        }
        
        /* The Problem */
        .problem {
            background: var(--bg-alt);
        }
        
        .problem-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 2rem;
            margin-top: 3rem;
        }
        
        .problem-card {
            background: white;
            padding: 2rem;
            border-radius: 12px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            text-align: center;
            transition: transform 0.3s ease;
        }
        
        .problem-card:hover {
            transform: translateY(-5px);
        }
        
        .problem-card .icon {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        
        .problem-card h3 {
            color: var(--dark);
            margin-bottom: 0.5rem;
        }
        
        .problem-card p {
            color: var(--gray);
            font-size: 0.95rem;
        }
        
        /* The Solution */
        .solution {
            background: white;
        }
        
        .solution-intro {
            background: linear-gradient(135deg, var(--success) 0%, #229954 100%);
            color: white;
            padding: 2rem;
            border-radius: 12px;
            margin-bottom: 3rem;
            text-align: center;
        }
        
        .solution-intro h3 {
            font-size: 1.5rem;
            margin-bottom: 0.5rem;
        }
        
        .scoring-breakdown {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
            margin: 3rem 0;
        }
        
        .score-item {
            background: var(--bg-alt);
            padding: 1.5rem;
            border-radius: 10px;
            text-align: center;
            border-left: 4px solid;
        }
        
        .score-item.binding { border-color: var(--primary); }
        .score-item.structure { border-color: var(--secondary); }
        .score-item.developability { border-color: var(--warning); }
        .score-item.immunogenicity { border-color: var(--accent); }
        
        .score-item .percent {
            font-size: 2.5rem;
            font-weight: 800;
            color: var(--dark);
        }
        
        .score-item .label {
            font-weight: 600;
            color: var(--gray);
            margin-top: 0.5rem;
        }
        
        /* Platforms */
        .platforms {
            background: var(--bg-alt);
        }
        
        .platform-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 1.5rem;
        }
        
        .platform-card {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.05);
            transition: all 0.3s ease;
        }
        
        .platform-card:hover {
            box-shadow: 0 8px 30px rgba(0,0,0,0.12);
            transform: translateY(-3px);
        }
        
        .platform-card h4 {
            color: var(--primary);
            margin-bottom: 0.5rem;
        }
        
        .platform-card .org {
            color: var(--gray);
            font-size: 0.85rem;
            margin-bottom: 1rem;
        }
        
        .platform-card .highlight {
            font-size: 0.9rem;
            padding: 0.5rem;
            background: var(--bg-alt);
            border-radius: 6px;
            margin-top: 0.5rem;
        }
        
        .platform-card.featured {
            border: 2px solid var(--purple);
            position: relative;
        }
        
        .platform-card.featured::before {
            content: 'First Immunogenicity Data';
            position: absolute;
            top: -10px;
            left: 50%;
            transform: translateX(-50%);
            background: var(--purple);
            color: white;
            padding: 0.2rem 0.8rem;
            border-radius: 10px;
            font-size: 0.7rem;
            font-weight: 600;
            white-space: nowrap;
        }
        
        /* Call to Action */
        .cta-section {
            background: linear-gradient(135deg, var(--dark) 0%, #34495e 100%);
            color: white;
            text-align: center;
            padding: 5rem 2rem;
        }
        
        .cta-section h2 {
            font-size: 2.5rem;
            margin-bottom: 1rem;
        }
        
        .cta-section p {
            font-size: 1.2rem;
            opacity: 0.9;
            max-width: 600px;
            margin: 0 auto 2rem;
        }
        
        .participation-options {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 2rem;
            margin: 3rem 0;
            text-align: left;
        }
        
        .participation-card {
            background: rgba(255,255,255,0.1);
            padding: 2rem;
            border-radius: 12px;
            backdrop-filter: blur(10px);
        }
        
        .participation-card h4 {
            font-size: 1.2rem;
            margin-bottom: 1rem;
            display: flex;
            align-items: center;
            gap: 0.5rem;
        }
        
        .participation-card ul {
            list-style: none;
            font-size: 0.95rem;
            opacity: 0.9;
        }
        
        .participation-card li {
            margin-bottom: 0.5rem;
            padding-left: 1.5rem;
            position: relative;
        }
        
        .participation-card li::before {
            content: '‚Üí';
            position: absolute;
            left: 0;
        }
        
        /* Timeline */
        .timeline {
            background: white;
        }
        
        .timeline-items {
            display: flex;
            justify-content: space-between;
            flex-wrap: wrap;
            gap: 1rem;
            margin-top: 3rem;
        }
        
        .timeline-item {
            flex: 1;
            min-width: 150px;
            text-align: center;
            padding: 1.5rem;
            background: var(--bg-alt);
            border-radius: 10px;
            position: relative;
        }
        
        .timeline-item::after {
            content: '';
            position: absolute;
            top: 50%;
            right: -20px;
            width: 20px;
            height: 2px;
            background: var(--gray);
            display: none;
        }
        
        @media (min-width: 768px) {
            .timeline-item:not(:last-child)::after {
                display: block;
            }
        }
        
        .timeline-item .date {
            font-weight: 700;
            color: var(--primary);
            margin-bottom: 0.5rem;
        }
        
        /* Footer */
        footer {
            background: var(--dark);
            color: white;
            padding: 3rem 2rem;
            text-align: center;
        }
        
        footer .links {
            margin-bottom: 2rem;
        }
        
        footer a {
            color: white;
            text-decoration: none;
            margin: 0 1rem;
            opacity: 0.8;
            transition: opacity 0.3s;
        }
        
        footer a:hover {
            opacity: 1;
        }
        
        /* Responsive */
        @media (max-width: 768px) {
            .hero h1 {
                font-size: 2rem;
            }
            
            .hero .subtitle {
                font-size: 1.1rem;
            }
            
            .section-header h2 {
                font-size: 1.8rem;
            }
            
            .cta-section h2 {
                font-size: 2rem;
            }
        }
        
        /* Utility */
        .highlight {
            background: linear-gradient(120deg, #ffeaa7 0%, #ffeaa7 100%);
            background-repeat: no-repeat;
            background-size: 100% 40%;
            background-position: 0 88%;
            padding: 0 4px;
        }
        
        .gatekeeper {
            background: var(--accent);
            color: white;
            padding: 0.2rem 0.6rem;
            border-radius: 4px;
            font-size: 0.8rem;
            font-weight: 600;
        }
    </style>
</head>
<body>
    <!-- Hero Section -->
    <header class="hero">
        <div class="hero-content">
            <div class="version">Version 6.0 ‚Ä¢ January 2026</div>
            <h1>DADB-v1.0:<br>A Therapeutic Decathlon</h1>
            <p class="subtitle">The first comprehensive benchmark for de novo antibody design that measures what actually matters: binding, structure, developability, and immunogenicity.</p>
            <div class="cta-buttons">
                <a href="#participate" class="btn btn-primary">
                    <span>üöÄ</span> Join the Consortium
                </a>
                <a href="v6_denovo-ab-design-benchmark_scientific-paper.pdf" class="btn btn-secondary">
                    <span>üìÑ</span> Read Full Paper
                </a>
            </div>
        </div>
    </header>

    <!-- PDF Download Banner -->
    <section style="background: var(--dark); color: white; padding: 1.5rem; text-align: center;">
        <div class="container" style="display: flex; align-items: center; justify-content: center; gap: 2rem; flex-wrap: wrap;">
            <div style="display: flex; align-items: center; gap: 1rem;">
                <span style="font-size: 2.5rem;">üìÑ</span>
                <div style="text-align: left;">
                    <strong style="font-size: 1.1rem;">Read the Full Scientific Paper</strong>
                    <p style="margin: 0; opacity: 0.8; font-size: 0.9rem;">25 pages ‚Ä¢ 5 platforms ‚Ä¢ Full methodology</p>
                </div>
            </div>
            <a href="v6_denovo-ab-design-benchmark_scientific-paper.pdf" class="btn btn-primary" style="background: white; color: var(--dark);">
                <span>‚¨áÔ∏è</span> Download PDF
            </a>
        </div>
    </section>

    <!-- The Problem -->
    <section class="problem">
        <div class="container">
            <div class="section-header">
                <h2>The Affinity Trap</h2>
                <p>Current benchmarks optimize for binding alone, creating a dangerous blind spot. A 1 pM binder that aggregates at 37¬∞C or triggers an immune response is clinically worthless.</p>
            </div>
            
            <div class="problem-grid">
                <div class="problem-card">
                    <div class="icon">üéØ</div>
                    <h3>Binding Only</h3>
                    <p>Existing benchmarks measure affinity but ignore the 85% of candidates that fail downstream gates.</p>
                </div>
                <div class="problem-card">
                    <div class="icon">üß™</div>
                    <h3>Developability Crisis</h3>
                    <p>Aggregation, poor solubility, and low thermostability kill programs after millions in investment.</p>
                </div>
                <div class="problem-card">
                    <div class="icon">‚ö†Ô∏è</div>
                    <h3>Immunogenicity Blindspot</h3>
                    <p>25% of late-stage clinical failures are due to anti-drug antibodies‚Äîyet no benchmark measures this.</p>
                </div>
                <div class="problem-card">
                    <div class="icon">üîí</div>
                    <h3>Proprietary Silos</h3>
                    <p>4 of 5 major platforms are closed-source, preventing fair comparison and reproducibility.</p>
                </div>
            </div>
        </div>
    </section>

    <!-- The Solution -->
    <section class="solution" id="solution">
        <div class="container">
            <div class="section-header">
                <h2>The Therapeutic Decathlon</h2>
                <p>DADB-v1.0 introduces a composite scoring system that treats antibody design as a multi-event competition‚Äîbecause real drug discovery is never single-metric.</p>
            </div>
            
            <div class="solution-intro">
                <h3>üé™ The Formula</h3>
                <p><strong>DADB Score = (0.40 √ó Binding) + (0.25 √ó Structure) + (0.20 √ó Developability) + (0.15 √ó Immunogenicity)</strong></p>
            </div>
            
            <div class="scoring-breakdown">
                <div class="score-item binding">
                    <div class="percent">40%</div>
                    <div class="label">Binding</div>
                    <p style="font-size: 0.85rem; margin-top: 0.5rem; color: var(--gray);">Affinity, kinetics, specificity</p>
                </div>
                <div class="score-item structure">
                    <div class="percent">25%</div>
                    <div class="label">Structure</div>
                    <p style="font-size: 0.85rem; margin-top: 0.5rem; color: var(--gray);">RMSD, CDR-H3 accuracy</p>
                </div>
                <div class="score-item developability">
                    <div class="percent">20%</div>
                    <div class="label">Developability</div>
                    <p style="font-size: 0.85rem; margin-top: 0.5rem; color: var(--gray);"><span class="gatekeeper">GATEKEEPER</span><br>Tm, aggregation, solubility</p>
                </div>
                <div class="score-item immunogenicity">
                    <div class="percent">15%</div>
                    <div class="label">Immunogenicity</div>
                    <p style="font-size: 0.85rem; margin-top: 0.5rem; color: var(--gray);">T-cell assays, cytokine release</p>
                </div>
            </div>
            
            <div style="background: var(--bg-alt); padding: 2rem; border-radius: 10px; margin-top: 2rem;">
                <h4 style="color: var(--accent); margin-bottom: 1rem;">üîê The Gatekeeper Architecture</h4>
                <p>Developability acts as a <strong>binary gate</strong>: fail any threshold (Tm < 60¬∞C, aggregation > 5%, solubility < 10 mg/mL, hydrophobicity flag) and receive <strong>zero</strong> for that component‚Äîregardless of picomolar affinity. No more pyrrhic victories.</p>
            </div>
        </div>
    </section>

    <!-- Platforms -->
    <section class="platforms" id="platforms">
        <div class="container">
            <div class="section-header">
                <h2>Five Platforms, One Benchmark</h2>
                <p>DADB-v1.0 enables fair comparison across both open-source and proprietary platforms through standardized APIs and containerized evaluation.</p>
            </div>
            
            <div class="platform-grid">
                <div class="platform-card">
                    <h4>JAM-2</h4>
                    <div class="org">Nabla Bio</div>
                    <p><strong>Strength:</strong> Highest consistent hit rates (39% VHH-Fc)</p>
                    <div class="highlight">‚ö° 57% pass all 4 developability criteria</div>
                </div>
                
                <div class="platform-card">
                    <h4>Chai-2</h4>
                    <div class="org">Chai Discovery</div>
                    <p><strong>Strength:</strong> Most extensive cryo-EM validation</p>
                    <div class="highlight">üî¨ 5 structures, 0.41‚Äì1.7 √Ö RMSD</div>
                </div>
                
                <div class="platform-card">
                    <h4>Origin-1</h4>
                    <div class="org">AbSci</div>
                    <p><strong>Strength:</strong> Zero-prior epitope targeting</p>
                    <div class="highlight">üéØ 4/10 novel epitope successes</div>
                </div>
                
                <div class="platform-card">
                    <h4>RFAntibody</h4>
                    <div class="org">Baker Lab</div>
                    <p><strong>Strength:</strong> Only fully open-source platform</p>
                    <div class="highlight">üîì MIT License, full reproducibility</div>
                </div>
                
                <div class="platform-card featured">
                    <h4>Latent-X2</h4>
                    <div class="org">Latent Labs</div>
                    <p><strong>Strength:</strong> Highest monomeric affinity + immunogenicity data</p>
                    <div class="highlight">üèÜ 26.2 pM ‚Ä¢ 10-donor human panel ‚Ä¢ No immune response</div>
                </div>
            </div>
            
            <div style="text-align: center; margin-top: 2rem; padding: 1.5rem; background: white; border-radius: 10px; box-shadow: 0 2px 10px rgba(0,0,0,0.05);">
                <p style="margin: 0; color: var(--gray);"><strong>The Immunogenicity Gap:</strong> Despite causing 25% of late-stage failures, <span class="highlight">Latent-X2 is the only platform with published human immunogenicity data.</span> DADB-v1.0 makes this a scored component for the first time.</p>
            </div>
        </div>
    </section>

    <!-- Timeline -->
    <section class="timeline">
        <div class="container">
            <div class="section-header">
                <h2>Roadmap</h2>
                <p>From public validation to clinical correlation‚Äîa phased approach to benchmark maturity.</p>
            </div>
            
            <div class="timeline-items">
                <div class="timeline-item">
                    <div class="date">Q1 2026</div>
                    <h4>v1.0 Launch</h4>
                    <p style="font-size: 0.9rem; color: var(--gray);">5-platform comparison, immunogenicity track</p>
                </div>
                <div class="timeline-item">
                    <div class="date">Q2 2026</div>
                    <h4>v1.5</h4>
                    <p style="font-size: 0.9rem; color: var(--gray);">Bispecifics, Fc engineering</p>
                </div>
                <div class="timeline-item">
                    <div class="date">Q4 2026</div>
                    <h4>v2.0</h4>
                    <p style="font-size: 0.9rem; color: var(--gray);">ADC track, linker-payload optimization</p>
                </div>
                <div class="timeline-item">
                    <div class="date">2027</div>
                    <h4>v2.5</h4>
                    <p style="font-size: 0.9rem; color: var(--gray);">Cell therapy, TCR design</p>
                </div>
                <div class="timeline-item">
                    <div class="date">2028</div>
                    <h4>v3.0</h4>
                    <p style="font-size: 0.9rem; color: var(--gray);">In vivo prediction, clinical correlation</p>
                </div>
            </div>
        </div>
    </section>

    <!-- Call to Action -->
    <section class="cta-section" id="participate">
        <div class="container">
            <h2>Join the Consortium</h2>
            <p>DADB's success depends on community participation. Whether you're an academic lab, AI platform, or biopharma partner, there's a role for you.</p>
            
            <div class="participation-options">
                <div class="participation-card">
                    <h4>üè´ Academic Labs</h4>
                    <ul>
                        <li>Submit open-source models</li>
                        <li>Contribute unpublished structures</li>
                        <li>Validate predictions experimentally</li>
                        <li>Join the Steering Committee</li>
                    </ul>
                </div>
                
                <div class="participation-card">
                    <h4>ü§ñ Platform Providers</h4>
                    <ul>
                        <li>API-based evaluation (IP-protected)</li>
                        <li>Earn "DADB-Validated" certification</li>
                        <li>Leaderboard recognition</li>
                        <li>Consortium membership</li>
                    </ul>
                </div>
                
                <div class="participation-card">
                    <h4>üíä Biopharma Partners</h4>
                    <ul>
                        <li>Validate predictions vs. clinical outcomes</li>
                        <li>Share developability datasets</li>
                        <li>Early access to benchmark targets</li>
                        <li>Methods paper co-authorship</li>
                    </ul>
                </div>
            </div>
            
            <div style="margin-top: 3rem;">
                <a href="mailto:spiff007@gmail.com?subject=DADB%20Consortium%20Inquiry" class="btn btn-primary" style="font-size: 1.2rem; padding: 1.2rem 2.5rem;">
                    <span>‚úâÔ∏è</span> Contact the Consortium
                </a>
                <p style="margin-top: 1rem; opacity: 0.7; font-size: 0.9rem;">Private test set targets are confidential and shared only under NDA</p>
            </div>
        </div>
    </section>

    <!-- PDF Section -->
    <section style="background: var(--bg-alt); padding: 4rem 2rem; text-align: center;">
        <div class="container">
            <span style="font-size: 4rem; margin-bottom: 1rem; display: block;">üìë</span>
            <h2 style="margin-bottom: 1rem; color: var(--dark);">Read the Full Proposal</h2>
            <p style="max-width: 600px; margin: 0 auto 2rem; color: var(--gray);">
                Download the complete 25-page scientific paper with detailed methodology, 
                platform comparisons, scoring formulas, and benchmark specifications.
            </p>
            <div style="display: flex; gap: 1rem; justify-content: center; flex-wrap: wrap;">
                <a href="v6_denovo-ab-design-benchmark_scientific-paper.pdf" class="btn btn-primary" style="background: var(--primary); color: white;">
                    <span>üì•</span> Download PDF (341 KB)
                </a>
                <a href="v6_denovo-ab-design-benchmark_scientific-paper.pdf" target="_blank" class="btn btn-secondary" style="border-color: var(--primary); color: var(--primary);">
                    <span>üëÅÔ∏è</span> View in Browser
                </a>
            </div>
            <p style="margin-top: 1.5rem; font-size: 0.85rem; color: var(--gray);">
                Version 6.0 ‚Ä¢ Security-reviewed and scientifically corrected ‚Ä¢ January 2026
            </p>
        </div>
    </section>

    <!-- Footer -->
    <footer>
        <div class="links">
            <a href="v6_denovo-ab-design-benchmark_scientific-paper.pdf">üìÑ Full Paper (PDF)</a>
            <a href="https://github.com/inventcures/dadb">üíª GitHub</a>
            <a href="#participate">ü§ù Participate</a>
        </div>
        <p style="opacity: 0.6; font-size: 0.9rem;">
            DADB-v1.0 ‚Ä¢ De Novo Antibody Design Benchmark Consortium ‚Ä¢ January 2026
        </p>
    </footer>
</body>
</html>
